The lymphokie interleukin 2 is an important immune system regulatory glycopolypeptide. It is produced by antigen-or mitogen-stimulated T lymphocytes and is required for the proliferation or clonal expansion of activated T lymphocytes. In this report, it is demonstrated by RNA transfer blot hybridization that the poly(A)+ RNA population of the human placenta contains a 0.85-kilobase RNA transcript that specifically hybridizes to a human interleukin 2 cDNA probe. By using hybridization histochemistry in situ, it is further shown that interleukin 2 RNA transcripts are localized, primarily, to the syncytial (syncytiotrophoblast) layer of the human placenta. Possible roles for syncytiotrophoblastproduced interleukin 2 are suggested and discussed.Interleukin 2 (IL-2), or T (thymus-dependent)-cell growth factor, is a 15,500-dalton glycoprotein that is produced by T lymphocytes after antigen or mitogen stimulation and is required for proliferation of activated T cells, which possess specific receptors for this growth factor (recently reviewed, refs. 1-9 Extraction and isolation of total RNA were accomplished by using guanidinium isothiocyanate (Fluka; purum) as described (28), and poly(A)+ RNA was selected from the total RNA by passage (twice) through oligo(dT)-cellulose (type 3, Collaborative Research) columns (29).RNA Transfer Blot Hybridization Analysis. Placental poly(A)+ RNA from differing stages of gestation was separated by electrophoresis through 1% agarose/formaldehyde denaturing minihorizontal submarine slab gels, transferred to nitrocellulose, and baked under vacuum for 2 hr at 80°C as described (30). Total RNA from placenta or an RNA ladder (Bethesda Research Laboratories) was separated simultaneously on the same minigels in an adjacent lane and stained with ethidium bromide for RNA size determination. Nitrocellulose-bound poly(A)+ RNA was hybridized with an [a-32P]dCTP nick-translated 700-base-pair (bp) human IL-2 coding region cDNA fragment (Oncor, Gaithersburg, MD) (1-5 x 107 cpm/,ug of DNA, 1 x 106 cpm/ml) in a solution containing 35% (vol/vol) formamide, 0.9 M NaCI/90 mM trisodium citrate, 0.1% sodium pyrophosphate, 0.1 M sodium phosphate (pH 7.0)